Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
marc.feldmann@kennedy.ox.ac.uk

Research groups

Websites

Feldmann Group | Unravelling the Role of Cytokines in Disease
Research Group, Kennedy Institute

Sir Marc Feldmann FRS

Emeritus Professor

Recent publications

Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.
Journal article

Lee G. et al, (2018), Proceedings of the national academy of sciences of the united states of america, 115, E4463 - E4472
Developments in therapy with monoclonal antibodies and related proteins.
Journal article

Shepard HM. et al, (2017), 17, 220 - 232
Anti-TNF Therapy.
Journal article

Udalova I. et al, (2016), Microbiology spectrum, 4
Macrophage heterogeneity in the context of rheumatoid arthritis.
Journal article

Udalova IA. et al, (2016), Nature reviews. rheumatology, 12, 472 - 485
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
Journal article

Cole JE. et al, (2015), Proceedings of the national academy of sciences of the united states of america, 112, 13033 - 13038

More publications